Literature DB >> 15643976

Mycophenolate mofetil: how to further improve using an already successful drug?

Teun van Gelder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15643976     DOI： 10.1111/j.1600-6143.2005.00793.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  3 in total

1.  Large scale analysis of routine dose adjustments of mycophenolate mofetil based on global exposure in renal transplant patients.

Authors:  Franck Saint-Marcoux; Soizic Vandierdonck; Aurélie Prémaud; Jean Debord; Annick Rousseau; Pierre Marquet
Journal:  Ther Drug Monit       Date:  2011-06       Impact factor: 3.681

Review 2.  Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.

Authors:  Olesja Rissling; Petra Glander; Pia Hambach; Marco Mai; Susanne Brakemeier; Daniela Klonower; Fabian Halleck; Eugenia Singer; Eva-Vanessa Schrezenmeier; Michael Dürr; Hans-Hellmut Neumayer; Klemens Budde
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.